View Older Stories View More Recent Stories

Feb 15, 2022 07:00AM Zynerba Pharmaceuticals Announces Planned Retirement of Suzanne Hanlon and Appoints Albert P. Parker as Chief Legal Officer
Feb 10, 2022 07:00AM Zynerba Pharmaceuticals to Present at the SVB Leerink Global Healthcare Conference
Feb 10, 2022 07:00AM Zynerba Pharmaceuticals to Present at the SVB Leerink Global Healthcare Conference
Jan 6, 2022 07:00AM Zynerba Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
Jan 6, 2022 07:00AM Zynerba Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
Jan 4, 2022 04:09PM Zynerba Pharma (ZYNE) Announces Clinical Development Updates for FXS, ASD, 22q and DEE
Jan 4, 2022 04:05PM Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE
Jan 4, 2022 04:05PM Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE
Dec 6, 2021 07:00AM Zynerba Pharmaceuticals Announces Presentation at The BRAIN Foundation Synchrony 2021 Symposium
Dec 6, 2021 07:00AM Zynerba Pharmaceuticals Announces Presentation at The BRAIN Foundation Synchrony 2021 Symposium
Nov 22, 2021 07:01AM Zynerba Pharma (ZYNE) Awarded New Zygel Patent in EU
Nov 22, 2021 07:00AM Zynerba Pharmaceuticals Announces Issuance of New Patent in EU for Zygel™
Nov 15, 2021 07:00AM Zynerba Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights
Nov 15, 2021 07:00AM Zynerba Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights
Oct 21, 2021 07:00AM Zynerba Pharmaceuticals Announces Presentations at Two Upcoming Scientific Conferences in October
Oct 21, 2021 07:00AM Zynerba Pharmaceuticals Announces Presentations at Two Upcoming Scientific Conferences in October
Oct 19, 2021 04:15PM Zynerba Pharmaceuticals Announces Presentation of Poster at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
Oct 19, 2021 04:15PM Zynerba Pharmaceuticals Announces Presentation of Poster at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit
Oct 8, 2021 07:30AM Zynerba Pharmaceuticals Announces Presentation of Poster at the 2021 American Academy of Pediatrics National Conference & Exhibition
Oct 8, 2021 07:30AM Zynerba Pharmaceuticals Announces Presentation of Poster at the 2021 American Academy of Pediatrics National Conference & Exhibition
Sep 20, 2021 07:00AM Zynerba Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
Sep 20, 2021 07:00AM Zynerba Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
Sep 13, 2021 07:00AM Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome
Sep 13, 2021 07:00AM Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel™ in Fragile X Syndrome
Sep 9, 2021 07:00AM Zynerba Pharmaceuticals Presents Longer Term Tolerability and Efficacy Data of Zygel™ in Children and Adolescents with Autism Spectrum Disorder (ASD) at The Society for the Study of Behavioural Phen
Sep 9, 2021 07:00AM Zynerba Pharmaceuticals Presents Longer Term Tolerability and Efficacy Data of Zygel™ in Children and Adolescents with Autism Spectrum Disorder (ASD) at The Society for the Study of Behavioural Phen
Sep 7, 2021 07:04AM Zynerba Pharma (ZYNE) Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Netwo
Sep 7, 2021 07:00AM Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Net
Sep 7, 2021 07:00AM Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Net
Sep 2, 2021 07:30AM Zynerba Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
Sep 2, 2021 07:30AM Zynerba Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
Sep 2, 2021 07:00AM Zynerba Pharmaceuticals Announces Oral Presentations at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021
Sep 2, 2021 07:00AM Zynerba Pharmaceuticals Announces Oral Presentations at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021
Aug 9, 2021 07:00AM Zynerba Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights
Aug 9, 2021 07:00AM Zynerba Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights
Aug 4, 2021 07:30AM Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
Aug 4, 2021 07:30AM Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
Jul 7, 2021 07:30AM Zynerba Pharmaceuticals to Present at the Ladenburg Thalmann Virtual Healthcare Conference
Jul 7, 2021 07:30AM Zynerba Pharmaceuticals to Present at the Ladenburg Thalmann Virtual Healthcare Conference
Jun 30, 2021 07:00AM Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
Jun 30, 2021 07:00AM Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
Jun 11, 2021 12:30PM Zynerba Pharma (ZYNE) Presents Sleep Data from Study of Zygel in Children and Adolescents with Both DEE and ASD at Associated Professional Sleep Societies SLEEP 2021 Annual
Jun 11, 2021 12:30PM Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the As
Jun 11, 2021 12:30PM Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the As
Jun 9, 2021 04:05PM Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
Jun 9, 2021 04:05PM Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting
Jun 4, 2021 07:30AM Zynerba Pharmaceuticals Announces Acceptance of Poster at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting
Jun 4, 2021 07:30AM Zynerba Pharmaceuticals Announces Acceptance of Poster at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting
Jun 3, 2021 10:03AM Zynerba Pharma (ZYNE) Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectrum Disorder and Related Disorders at ASCP
Jun 3, 2021 10:00AM Zynerba Pharmaceuticals Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectrum Disorder (ASD) and Related Disorders at the 2021 American Society of Cli
View More Recent Stories View Older Stories